908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026)
908 Devices' (MASS) quarterly Liabilities and Shareholders Equity came in at $186.7 million in Q1 2026, down 4.76% year-on-year from $196.0 million in Q1 2025, and down 1.78% on a QoQ basis from $190.1 million in Q4 2025.
908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $186.7 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 4.76% year-over-year to $186.7 million in Q1 2026; TTM through Mar 2026 was $759.3 million, a 2.26% increase from a year earlier, with the FY2025 full-year figure at $190.1 million, up 19.18% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $186.7 million, down from $190.1 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for MASS reached as high as $251.2 million in Q1 2022 and fell as low as $159.5 million in Q4 2024.
- Historically, Liabilities and Shareholders Equity has averaged $207.2 million across 5 years, with a median of $203.0 million in 2023.
- Across the five-year window, Liabilities and Shareholders Equity surged 49.9% in 2022 and declined 21.43% in 2024, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $242.6 million in 2022, then declined by 16.33% to $203.0 million in 2023, then retreated by 21.43% to $159.5 million in 2024, then gained by 19.18% to $190.1 million in 2025, then dropped by 1.78% to $186.7 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $186.7 million in Q1 2026, $190.1 million in Q4 2025, and $190.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 13.32 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 37.13 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 6.63 Bn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 31.92 Bn |
| 10 | 908 Devices | 269.51 Mn | 157.77 Mn | 6.88 Mn | 186.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.70 Mn |
| Dec 31, 2025 | 190.07 Mn |
| Sep 30, 2025 | 190.87 Mn |
| Jun 30, 2025 | 191.70 Mn |
| Mar 31, 2025 | 196.03 Mn |
| Dec 31, 2024 | 159.48 Mn |
| Sep 30, 2024 | 178.28 Mn |
| Jun 30, 2024 | 208.77 Mn |
| Mar 31, 2024 | 189.79 Mn |
| Dec 31, 2023 | 202.98 Mn |
| Sep 30, 2023 | 208.48 Mn |
| Jun 30, 2023 | 210.83 Mn |
| Mar 31, 2023 | 218.41 Mn |
| Dec 31, 2022 | 242.59 Mn |
| Sep 30, 2022 | 249.28 Mn |
| Jun 30, 2022 | 247.00 Mn |
| Mar 31, 2022 | 251.23 Mn |
| Dec 31, 2021 | 260.91 Mn |
| Sep 30, 2021 | 166.30 Mn |
| Jun 30, 2021 | 166.48 Mn |